查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190809

眼保健品市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Eye Health Supplement Market- Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內（2022 年至 2027 年），眼保健品市場預計將以 6.5% 的複合年增長率增長。

自世界衛生組織於 2020 年 3 月 11 日宣布 2019 年冠狀病毒病（或 COVID-19）為大流行病以來，世界上許多國家/地區都實施了全國封鎖。 為最大程度地降低傳播 COVID-19 的風險，暫停了常規醫療保健服務，並建議患者除非絕對必要，否則不要去醫院就診。 這些趨勢嚴重擾亂了眼科保健服務和患者護理的提供。 根據 2020 年 10 月發表的一項題為“COVID-19 大流行對眼科服務的影響：我們準備好迎接善後了嗎？”的研究，眼科是最繁忙、門診病人最多的專科之一。它代表了大約 750 萬次門診預約等等英國每年有超過 500,000 例外科手術。 最近的大流行封鎖取消了數千次眼科門診就診和手術，可能對患者的視力造成永久性和重大損害。 另據報導，COVID-19 大流行對印度的眼科服務產生了重大影響，臨床和外科服務下降了 95% 以上。 就診人數的下降影響了眼保健品在患者群體中的應用。 然而，隨著遠程醫療和虛擬護理實踐的開展，對眼保健品的需求在不久的將來可能會激增至大流行前的水平。 因此，在大流行初期，這種選擇性對市場增長產生了負面影響，例如取消了例行的眼科檢查。 然而，預計該市場在未來幾年將獲得更大的吸引力。

推動眼保健品市場增長的主要因素是全球眼病患病率上升。 由於不受控制的糖尿病會導致糖尿病性視網膜病變，因此預計研究目標市場將受到全球老年人口和糖尿病不斷增加的推動。 根據聯合國《2019年世界人口老齡化報告》，2019年全球65歲及以上人口為7.03億，預計到2050年將翻一番，達到15億。 根據世界衛生組織2021年的統計，全球至少有22億人患有近視或遠視。 對於這些人中至少有 10 億人（將近一半）來說，視力喪失本可以得到預防或尚未得到解決。 此外，根據乾眼症目錄 2022 年的統計數據，現在有 16 至 4900 萬美國人患有乾眼症。 這佔人口的 5-15%。 眼病患病率的增加可能會刺激患者群體對眼保健品的需求。

此外，創新產品的推出也在推動市場的增長。 例如，2021 年 7 月，Healthy Directions 宣布推出 Vision Essentials ULTRA，這是其廣受歡迎且有效的 Whitaker Nutrition 系列的突破性日常視力補充劑。 同樣，2021 年 5 月，PharmaLinea 以消費者友好的形式推出了一系列預防性眼保健品。 該決定是由於大流行導致屏幕時間增加和眼睛健康問題增加。 同樣在 2021 年 2 月，Univer Inc.宣布與 Health Thru Nutrition 合作推出 Health Thru Nutrition 辣椒紅素補充劑，包括 CapsiClear。

因此，由於上述因素，預計所研究的市場將在預測期內得到推動。 然而，與眼保健品相關的高成本可能會阻礙市場增長。

主要市場趨勢

預計抗氧化劑板塊在預測期內將呈現更好的增長

老年人口的增加、糖尿病患病率的上升、年齡相關性黃斑變性 (AMD) 等眼病、白內障和糖尿病性視網膜病變預計將推動北美研究市場的增長。 此外，黃斑變性通常稱為年齡相關性黃斑變性 (AMD)，是一種與年齡相關的眼病，會導致銳利和中心視力喪失。 根據 2021 年黃斑變性研究，黃斑變性是 60 歲以上美國人視力喪失的主要原因。 在美國，多達 1100 萬人患有某種形式的年齡相關性黃斑變性。 到 2050 年，這一數字預計將翻一番，達到 2200 萬。 年齡是年齡相關性黃斑變性的主要危險因素。 據說 50-59 歲的人患晚期老年性黃斑變性的風險增加到 2%，75 歲及以上的人增加近 30%。

此外，該地區主要參與者的集中和新產品發布的增加正在推動所研究市場的增長。 例如，2019 年 7 月，博士倫在美國推出了 Ocuvite Eye Performance，這是一種具有七種關鍵營養素的眼部維生素，可強化黃斑部並保護眼睛免受壓力。 同樣，主要參與者正在實施各種戰略，例如研發投資、合作和收購，以擴大其在該地區的產品組合。 其中之一是與 ZeaVision LLC (iPromise) 的合作協議。 (IPromise) 於 2019 年 11 月與波士頓紅襪隊合作，成為整個 2020 年的官方 iVitamin 品牌。

2021 年 12 月，得克薩斯州營養補充劑公司 TJ Nutrition 根據遺傳病研究人員的臨床研究創造了一種獨一無二的專利補充劑，將在減少炎症的同時增加淚液生成。宣布推出一種科學的經過驗證的突破性專利化合物 Parasim Plus Eyes。 Parasim Plus Eyes 可增強淚腺和迷走神經的功能，從而改善神經系統並同時改善全身和眼部健康。

因此，由於上述因素，北美有望在預測期內對眼保健品市場做出重大貢獻。

北美在眼部保健品市場佔據主導地位，預計在預測期內將經歷巨大增長

老年人口的增加、糖尿病患病率的上升、年齡相關性黃斑變性 (AMD) 等眼病、白內障和糖尿病性視網膜病變預計將推動北美研究市場的增長。 此外，黃斑變性通常稱為年齡相關性黃斑變性 (AMD)，是一種與年齡相關的眼病，會導致銳利和中心視力喪失。 根據 2021 年黃斑變性研究，黃斑變性是 60 歲以上美國人視力喪失的主要原因。 在美國，多達 1100 萬人患有某種形式的年齡相關性黃斑變性。 到 2050 年，這一數字預計將翻一番，達到 2200 萬。 年齡是年齡相關性黃斑變性的主要危險因素。 據說 50-59 歲的人患晚期老年性黃斑變性的風險增加到 2%，75 歲及以上的人增加近 30%。

此外，該地區主要參與者的集中和新產品發布的增加正在推動所研究市場的增長。 例如，2019 年 7 月，博士倫在美國推出了 Ocuvite Eye Performance，這是一種具有七種關鍵營養素的眼部維生素，可強化黃斑部並保護眼睛免受壓力。 同樣，主要參與者正在實施各種戰略，例如研發投資、合作和收購，以擴大其在該地區的產品組合。 其中之一是 ZeaVision LLC. (IPromise) 於 2019 年 11 月與波士頓紅襪隊合作，成為整個 2020 年的官方 iVitamin 品牌。

2021 年 12 月，得克薩斯州營養補充劑公司 TJ Nutrition 根據遺傳病研究人員的臨床研究創造了一種獨一無二的專利補充劑，將在減少炎症的同時增加淚液生成。宣布推出一種科學的經過驗證的突破性專利化合物 Parasim Plus Eyes。 Parasim Plus Eyes 可增強淚腺和迷走神經的功能，從而改善神經系統並同時改善全身和眼部健康。

由於上述原因，預計在預測期內，北美將對眼保健品市場做出重大貢獻。

競爭格局

眼睛保健品市場競爭激烈，由許多主導市場的大型企業組成。 此外，許多中小企業也積極參與研發活動，並希望進軍研究市場，這將在預測期內帶來爆炸式增長。 研究市場的主要參與者包括 Bausch & Lomb, Incorporated、ZeaVision, LLC、Amway International、Akorn Consumer Health、Vitabiotics Ltd、Nature's Bounty, Co. 等。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 眼病患病率增加
    • 老齡化人口的增加和糖尿病患病率的增加
    • 在日常生活中更多地使用屏幕和顯示器
  • 市場製約因素
    • 眼保健品費用高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按類型
    • 抗氧化劑
    • 脂肪酸
    • 抗炎補充劑
    • 神經保護補充劑
    • 其他
  • 根據指示
    • 年齡相關性黃斑變性 (AMD)
    • 白內障
    • 乾眼症
    • 糖尿病視網膜病變
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Bausch & Lomb Incorporated
    • Pfizer, Inc.
    • Amway International
    • Akorn Consumer Health
    • Vitabiotics Ltd
    • ZeaVision, LLC
    • Nature's Bounty Co.
    • Nutrivein
    • Kemin Industries, Inc.
    • EyeScience Labs
    • Zenith Labs
    • Performance Lab Ltd.
    • Nuzena LLC

第7章 市場機會與今後動向

簡介目錄
Product Code: 71834

The eye health supplement market is projected to register a CAGR of 6.5% during the forecast period (2022-2027).

Many countries around the world have imposed nationwide lockdowns since the World Health Organization declared Coronavirus Disease 2019 (or COVID-19) to be a pandemic on March 11, 2020. Routine healthcare services were canceled, and patients were advised to avoid hospital visits unless critically necessary, to minimize the risk of COVID-19 transmission. These trends led to significant disruption to the provision of eye healthcare services and patient care. As per the study published in October 2020, titled "The impact of COVID-19 pandemic on ophthalmology services: are we ready for the aftermath?", ophthalmology represented one of the busiest and most heavily outpatient-oriented specialties, with approximately 7.5 million outpatient appointments and more than 500,000 surgical procedures in United Kingdom each year. The recent pandemic lockdown resulted in the cancellation of thousands of ophthalmic clinical visits and surgeries, which could potentially lead to permanent and significant harm to patients' vision. The study also reported a significant impact of the COVID-19 pandemic on the ophthalmology service in India, with clinical and surgical services being reduced by >95%. Such a decrease in patient visits impacted the adoption of eye health supplements among the patient population. However, owing to teleconsultations and virtual care practices, the demand for eye health supplements is likely to soar to its pre-pandemic levels in the near future. Thus, in view of its elective nature, the cancellation of routine ophthalmic visits in the initial pandemic phase had an adverse impact on the market's growth. However, the market is anticipated to gain traction over the coming years.

The major drivers propelling the growth of the eye health supplement market are the increasing prevalence of eye disorders globally. The studied market is expected to be driven by the growing global geriatric population and diabetes, as uncontrolled diabetes leads to diabetic retinopathy. According to the United Nations, World Population Ageing 2019, there were 703 million people aged 65 years or over in the world in 2019, and the number is projected to double to 1.5 billion in 2050. As per the World Health Organization Statistics of 2021, globally, at least 2.2 billion people have a near-or distance vision impairment. In at least 1 billion, or almost half of these cases, vision impairment could have been prevented or has yet to be addressed. Furthermore, as per the Dry Eye Directory's statistics for 2022, between 16 million and 49 million Americans currently have dry eyes. This is between 5-15% of the population. The increasing prevalence of eye disorders is likely to impel the demand for eye health supplements among the patient population.

Besides, the launch of innovative products is also boosting the market's growth. For instance, in July 2021, Healthy Directions announced the introduction of Vision Essentials ULTRA, a breakthrough one-a-day vision supplement in its highly popular and efficacious Whitaker Nutrition line. Likewise, in May 2021, PharmaLinea launched a line of preventative eye health supplements in consumer-friendly formats. The decision came as a result of the pandemic, which has increased screen time and contributed to an increase in eye health concerns. Also, in February 2021, Unibar Corporation announced a partnership with Health Thru Nutrition and the availability of the Health Thru Nutrition Capsanthin supplement containing CapsiClear.

Thus, owing to the aforementioned factors, the studied market is expected to propel over the forecast period. However, higher costs associated with eye health supplement products are likely to impede market growth.

Key Market Trends

Antioxidant Segment is Expected to Show Better Growth over the Forecast Period

The rise in the geriatric population, the increasing prevalence of diabetes, and eye disorders such as age-related macular degeneration (AMD), cataract, diabetic retinopathy, and other eye disorders are expected to drive the growth of the studied market in North America. Besides, macular degeneration, often called age-related macular degeneration (AMD), is an eye disorder associated with aging and results in damaged sharp and central vision. As per the Macular Degeneration Research 2021, macular degeneration is a leading cause of vision loss in Americans aged 60 years of age and older. As many as 11 million people in United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. Age is a prominent risk factor for age-related macular degeneration. The risk of getting advanced age-related macular degeneration increases from 2% for those ages 50-59 to nearly 30% for those over the age of 75.

Additionally, the increasing concentration of major players and new product launches in the region adds to the growth of the studied market. For instance, in July 2019, Bausch + Lomb launched Ocuvite Eye Performance, an eye vitamin supplement formulated with seven vital nutrients that help strengthen the macula and protect the eye from stress in United States. Likewise, the major players are evolving various strategies, such as investment in research and development, collaborations, and acquisitions, for the expansion of their product portfolios in the region. One such collaboration was the partnership agreement of ZeaVision LLC. (EyePromise) with the Boston Red Sox in November 2019 as an official eye vitamin brand throughout 2020.

In December 2021, TJ Nutrition, a Texas nutraceutical company that creates one-of-a-kind, patented supplements based on genetic disease investigators' clinical research, announced the launch of Parasym Plus Eyes, a revolutionary and patented compound scientifically proven to increase tear production while reducing inflammation. By enhancing both lacrimal and vagus nerve function, Parasym Plus Eyes improves both systemic and ocular health neurologically and concurrently.

Thus, in view of the aforementioned factors, North America is expected to contribute significantly to the eye health supplement market over the forecast period.

North America has a Dominant Share in Eye Health Supplements Market and is Anticipated to Grow Tremendously over the Forecast Period

The rise in the geriatric population, the increasing prevalence of diabetes, and eye disorders such as age-related macular degeneration (AMD), cataract, diabetic retinopathy, and other eye disorders are expected to drive the growth of the studied market in North America. Besides, macular degeneration, often called age-related macular degeneration (AMD), is an eye disorder associated with aging and results in damaged sharp and central vision. As per the Macular Degeneration Research 2021, macular degeneration is a leading cause of vision loss in Americans aged 60 years of age and older. As many as 11 million people in United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. Age is a prominent risk factor for age-related macular degeneration. The risk of getting advanced age-related macular degeneration increases from 2% for those ages 50-59 to nearly 30% for those over the age of 75.

Additionally, the increasing concentration of major players and new product launches in the region adds to the growth of the studied market. For instance, in July 2019, Bausch + Lomb launched Ocuvite Eye Performance, an eye vitamin supplement formulated with seven vital nutrients that help strengthen the macula and protect the eye from stress in United States. Likewise, the major players are evolving various strategies, such as investment in research and development, collaborations, and acquisitions, for the expansion of their product portfolios in the region. One such collaboration was the partnership agreement of ZeaVision LLC. (EyePromise) with the Boston Red Sox in November 2019 as an official eye vitamin brand throughout 2020.

In December 2021, TJ Nutrition, a Texas nutraceutical company that creates one-of-a-kind, patented supplements based on genetic disease investigators' clinical research, announced the launch of Parasym Plus Eyes, a revolutionary and patented compound scientifically proven to increase tear production while reducing inflammation. By enhancing both lacrimal and vagus nerve function, Parasym Plus Eyes improves both systemic and ocular health neurologically and concurrently.

Thus, in view of the aforementioned factors, North America is expected to contribute significantly to the eye health supplement market over the forecast period.

Competitive Landscape

The Eye Health Supplement market is highly competitive and consists of many major players that dominate the market. Also, many small and medium-sized companies are also actively involved in R&D activities and trying to set foot in the studied market, thereby leading to an impactable growth over the forecast period. The major players in the studied market are Bausch & Lomb, Incorporated, ZeaVision, LLC., Amway International, Akorn Consumer Health, Vitabiotics Ltd, and Nature's Bounty, Co., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Eye disorders
    • 4.2.2 Growing Geriatric Population and High Incidence of Diabetes
    • 4.2.3 Increased Usage of Screens and Monitors in Daily Routine
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Eye Care Supplements
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Antioxidants
    • 5.1.2 Fatty Acids
    • 5.1.3 Anti-inflammatory Supplements
    • 5.1.4 Neuro-Protective Supplements
    • 5.1.5 Others
  • 5.2 By Indication
    • 5.2.1 Age-Related Macular Degeneration (AMD)
    • 5.2.2 Cataract
    • 5.2.3 Dry Eye Syndrome
    • 5.2.4 Diabetic Retinopathy
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bausch & Lomb Incorporated
    • 6.1.2 Pfizer, Inc.
    • 6.1.3 Amway International
    • 6.1.4 Akorn Consumer Health
    • 6.1.5 Vitabiotics Ltd
    • 6.1.6 ZeaVision, LLC
    • 6.1.7 Nature's Bounty Co.
    • 6.1.8 Nutrivein
    • 6.1.9 Kemin Industries, Inc.
    • 6.1.10 EyeScience Labs
    • 6.1.11 Zenith Labs
    • 6.1.12 Performance Lab Ltd.
    • 6.1.13 Nuzena LLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS